PDS Biotechnology Corp. (PDSB)
0.2947
-0.01
(-1.77%)
USD |
NASDAQ |
Sep 09, 12:20
PDS Biotechnology Debt to Equity Ratio : -1.219 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.219 |
| March 31, 2026 | 4.075 |
| December 31, 2025 | 1.829 |
| September 30, 2025 | 1.901 |
| June 30, 2025 | 1.162 |
| March 31, 2025 | 0.8479 |
| December 31, 2024 | 1.148 |
| September 30, 2024 | 1.121 |
| June 30, 2024 | 0.7885 |
| March 31, 2024 | 0.6484 |
| December 31, 2023 | 0.9128 |
| September 30, 2023 | 0.9641 |
| June 30, 2023 | 0.7249 |
| March 31, 2023 | 0.5732 |
| December 31, 2022 | 0.5335 |
| September 30, 2022 | 0.4964 |
| June 30, 2022 | 0.0077 |
| March 31, 2022 | 0.0082 |
| December 31, 2021 | 0.0078 |
| September 30, 2021 | 0.0077 |
| June 30, 2021 | 0.0076 |
| March 31, 2021 | 0.0239 |
| December 31, 2020 | 0.0225 |
| September 30, 2020 | 0.0206 |
| June 30, 2020 | 0.0391 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0615 |
| March 31, 2019 | 0.0565 |
| December 31, 2018 | -0.0145 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.472 |
| December 31, 2017 | 0.328 |
| September 30, 2017 | 0.2724 |
| June 30, 2017 | 0.2399 |
| March 31, 2017 | 0.1918 |
| December 31, 2016 | 0.1675 |
| September 30, 2016 | 0.152 |
| June 30, 2016 | 0.0402 |
| March 31, 2016 | 0.0419 |
| December 31, 2015 | 0.0432 |
| September 30, 2015 | 0.1385 |
| June 30, 2015 | 0.1125 |
| March 31, 2015 | 1.563 |
| December 31, 2014 | 0.3119 |
| September 30, 2014 | -1.659 |
| June 30, 2014 | |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.807M |
| Total Liabilities (Quarterly) | 12.39M |
| Shareholders Equity (Quarterly) | -3.580M |
| Current Ratio | 0.5692 |
| Net Debt Paydown Yield | 5.92% |